Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care

References

• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341–1351.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374:721–732.
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523–532.
   PubMed Web of Science ®Google Scholar
• Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370:741–750.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, GarcÌa-RÌo F, MuÒoz L, Duran-TaulerÌa E, S·nchez G, et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64:863–868.
   PubMed Web of Science ®Google Scholar
• Decramer M, Miravitlles M, Price D, Rom·n-RodrÌguez M, Llor C, Welte T, et al. New horizons in early stage COPD –Improving knowledge, detection and treatment. Respir Med 2011; 105:1576–1587.
   PubMed Web of Science ®Google Scholar
• Jones RCM, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014, forthcoming.
   Google Scholar
• Monteagudo M, Rodriguez-Blanco T, Parcet J, PeÒalver N, Rubio C, Ferrer M, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in Primary Care. Arch Bronconeumol 2011; 47:226–233.
   PubMed Web of Science ®Google Scholar
• Van Schayck C, Loozen J, Wagena E, Akkermans R, Wesseling G. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. Br Med J 2002; 324:1370.
   PubMed Web of Science ®Google Scholar
• Jordan RE, Lam KH, Cheng KK, Miller MR, Marsh JL, Ayres JG, et al. Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach. Thorax 2010; 65:492–498.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Andreu I, Romero Y, Sitjar S, AltÈs A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract 2012; 62:e68–e75.
   PubMed Web of Science ®Google Scholar
• Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006; 28:945–952.
   PubMed Web of Science ®Google Scholar
• Castell E, Garolera D, Vilella A, Grenzer V, Canela J. AdaptaciÛ al catal‡ de l'enquesta de malalties respiratories ATS-DLD-78. ValidaciÛ preliminar. Ann Med (Barc) 1988; 74:231–239.
   Google Scholar
• MonsÛ E, Ribas J, Carreres A, Izquierdo J, Alvarez J, Fiz J, et al. DiseÒo de un cuestionario ocupacional para ser utilizado en la pr·ctica neumolÛgica diaria. Ann Med (Barc) 1993; (3):43–46.
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez R, et al. Spirometric reference values from Mediterranean population. Bull Eur Physiopathol Respir 1986; 22:217–224.
   PubMedGoogle Scholar
• Vestbo J, Hurd SS, AgustÌ AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347–365.
   PubMed Web of Science ®Google Scholar
• GLI-2012 Desktop Software for Data Sets. http://www.lungfunction.org/tools/90-equations-and-tools/196-obtain-software.html (accessed 10 May, 2014).
   Google Scholar
• Vidal R, Blanco I, Casas F, JardÌ R, Miravitlles M. Guidelines for the diagnosis and management of alpha-1antitrypsin deficiency. Arch Bronconeumol 2006; 42:645–659.
   PubMed Web of Science ®Google Scholar
• RodrÌguez F, JardÌ R, Costa X, Cotrina M, Galimany R, Vidal R, et al. Rapid screening for alpha-1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood spots. Am J Respir Crit Care Med 2002; 166:814–817.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155:179–191.
   PubMed Web of Science ®Google Scholar
• Sobradillo PeÒa V, Miravitlles M, Gabriel R, JimÈnez-Ruiz C, Villasante C, Masa J, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118(4):981–989.
   PubMed Web of Science ®Google Scholar
• Jaén Díaz J, de Castro Mesa C, Gontán García-Salamanca M, López de Castro F. Prevalencia y factores de riesgo de EPOC en fumadores y ex fumadores. Arch Bronconeumol 2003; 39:554–558.
   PubMedGoogle Scholar
• Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J 2007; 9:800–802.
   PubMed Web of Science ®Google Scholar
• De Torres J, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006; 73:306–310.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Cha E, M Scharf S. Chronic obstructive pulmonary disease as an independent risk factor cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4:337–349.
   PubMedGoogle Scholar
• Miravitlles M, Soler-CataluÒa JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish Guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 2014; 50 (Suppl 1):1–16.
   PubMed Web of Science ®Google Scholar
• Molloy K, Hersh CP, Morris VB, Carroll TP, O'Connor CA, Lasky-Su J, et al. Clarification of the risk of chronic obstructive pulmonary disease in alpha1-antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014; 189:419–427.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabriel R, et al. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 2005; 99:985–995.
   PubMed Web of Science ®Google Scholar
• Medbo A, Melbye H. Lung function testing in the elderly –Can we still use FEV1/FVC<70% as a criterion for COPD? Respir Med 2007; 101:1097–1105.
   PubMed Web of Science ®Google Scholar
• Akkermans RP, Berrevoets MA, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, et al. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012; 12:12.
   PubMedGoogle Scholar
• Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63:768–774.
   PubMed Web of Science ®Google Scholar
• Barisione G, Crimi E, Bartolini S, Saporiti R, Copello F, Pellegrino R, et al. How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1. Eur Respir J 2009; 33:1396–1402.
   PubMed Web of Science ®Google Scholar